Cargando…
Brain NMDA Receptors in Schizophrenia and Depression
N-methyl-D-aspartate (NMDA) receptor antagonists such as phencyclidine (PCP), dizocilpine (MK-801) and ketamine have long been considered a model of schizophrenia, both in animals and humans. However, ketamine has been recently approved for treatment-resistant depression, although with severe restri...
Autor principal: | Adell, Albert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355879/ https://www.ncbi.nlm.nih.gov/pubmed/32585886 http://dx.doi.org/10.3390/biom10060947 |
Ejemplares similares
-
Multi-Scale Understanding of NMDA Receptor Function in Schizophrenia
por: Hyun, Jo Soo, et al.
Publicado: (2020) -
NMDA Receptor Antagonists for Treatment of Depression
por: Ates-Alagoz, Zeynep, et al.
Publicado: (2013) -
Is Memantine Effective as an NMDA Receptor Antagonist in Adjunctive Therapy for Schizophrenia?
por: Kikuchi, Tetsuro
Publicado: (2020) -
Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia
por: Nakazawa, Kazu, et al.
Publicado: (2017) -
Potential Roles for the GluN2D NMDA Receptor Subunit in Schizophrenia
por: Vinnakota, Chitra, et al.
Publicado: (2023)